SCHEMBL2076643

SCHEMBL2076643

O=C(O)c1ccc(Cl)c2c1-c1ccccc1C2=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
ALDH1A1 P00352 6/20 0.59
LMNA P02545 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
ADORA2A P29274 1/20 0.54
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPK1 P28482 4/20 0.53
THRB P10828 2/20 0.53
POLB P06746 2/20 0.53
RECQL P46063 1/20 0.53
TTR P02766 2/20 0.51
KDM4E B2RXH2 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
MMP14 P50281 1/20 0.49
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11878475 0.95 MAPT (0.61) MAPTALDH1A1LMNAL3MBTL1ADORA2A
SCHEMBL16224285 0.87 MAPT (0.69) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL29568790 0.83 MAPT (0.74) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL71118 0.83 MAPT (0.74) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL1652930 0.81 ALDH1A1 (0.57) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL308115 0.81 ADORA2A (0.76) MAPTALDH1A1LMNAL3MBTL1ADORA2A
SCHEMBL8496259 0.80 ALDH1A1 (0.59) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL27736815 0.79 MAPT (0.59) MAPTALDH1A1LMNAL3MBTL1MEN1
Methoxymethane SCHEMBL8415315 0.77 MAPT (0.65) MAPTALDH1A1LMNAL3MBTL1MEN1
SCHEMBL3453760 0.76 MAPT (0.66) MAPTALDH1A1LMNAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9563138-B2 Electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2017-02-07 US disclosed
US-20160238955-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2016-08-18 US disclosed
US-9335644-B2 Electron transport material, electrophotographic photoreceptor, process cartridge, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2016-05-10 US disclosed
US-20160085164-A1 ELECTRON TRANSPORT MATERIAL, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2016-03-24 US disclosed
US-8163750-B2 Fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone HSP 90 SANOFI-AVENTIS (FR) 2012-04-24 US disclosed
US-20100130503-A1 NEW FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING THE SAME AND USE THEREOF AS INHIBITORS OF THE PROTEIN CHAPERONE HSP 90 SANOFI-AVENTIS (FR) 2010-05-27 US disclosed
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed
US-20070219197-A1 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives ASTELLAS PHARMA GMBH (DE) 2007-09-20 US disclosed
US-20070142377-A1 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives BIEDERMANN ELFI 2007-06-21 US disclosed
US-20040009967-A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immuno-suppressives KLINGE PHARMA GMBH 2004-01-15 US disclosed
EP-0923570-B1 PYRIDYL ALKENE- AND PYRIDYL ALKINE- ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES FUJISAWA DEUTSCHLAND GMBH (DE) 2002-09-25 EP disclosed
US-5747206-A Electrophotographic photoreceptor FUJI XEROX CO., LTD. (JP) 1998-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160085164-A1 ELECTRON TRANSPORT MATERIAL, ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS GRK1, NR2E3, ATXN2L MAPT 4324/4885ALDH1A1 1389/4885LMNA 2714/4885
US-20070219197-A1 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives NFATC1, PDCD1, ACIN1 MAPT 4047/4885ALDH1A1 690/4885LMNA 4358/4885
US-20040009967-A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immuno-suppressives IDO1, ALK, ARG1 MAPT 4119/4885ALDH1A1 173/4885LMNA 4478/4885
US-20070142377-A1 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives ALK, TYMP, PDCD1 MAPT 3831/4885ALDH1A1 266/4885LMNA 4007/4885
US-20100130503-A1 NEW FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING THE SAME AND USE THEREOF AS INHIBITORS OF THE PROTEIN CHAPERONE HSP 90 HSP90AB2P, HSPA2, HSP90AB1 MAPT 1323/4885ALDH1A1 2540/4885LMNA 2105/4885
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 MAPT 844/4885ALDH1A1 3050/4885LMNA 3461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.